ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 1692

$527K Total Retail Price of All Prescriptions

Rank: 223 out of 1692

579 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,102 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 537 470 1 1
HYDROCHLOROTHIAZIDE 466 442 2 9
LISINOPRIL 427 341 3 2
METFORMIN HCL 349 276 4 8
AMLODIPINE BESYLATE 333 298 5 3
LEVOTHYROXINE SODIUM 324 262 6 4
METOPROLOL TARTRATE 303 261 7 10
OMEPRAZOLE 285 230 8 5
FUROSEMIDE 234 202 9 7
ATORVASTATIN CALCIUM 228 193 10 11
HYDROCODONE-ACETAMINOPHEN 225 146 S3 11 6
ATENOLOL 215 187 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 210 184 13 19
CITALOPRAM HBR 209 134 14 21
GLIMEPIRIDE 169 120 15 32
WARFARIN SODIUM 160 153 16 14
ZOLPIDEM TARTRATE 153 103 17 23
CARVEDILOL 142 130 18 24
GABAPENTIN 140 68 19 13
PAROXETINE HCL 133 121 20 60
ALENDRONATE SODIUM 132 128 21 36
DONEPEZIL HCL 130 117 22 29
LOSARTAN POTASSIUM 124 124 23 17
TRAMADOL HCL 120 79 24 16
PRAVASTATIN SODIUM 116 101 25 12
MELOXICAM 115 83 26 41
NIFEDIPINE ER 111 101 27 114
TRAZODONE HCL 107 88 28 33
RAMIPRIL 105 87 29 108
METOPROLOL SUCCINATE 96 94 30 18
PANTOPRAZOLE SODIUM 93 80 31 39
SPIRIVA 92 64 32 44
ALLOPURINOL 89 80 33 30
VENLAFAXINE HCL ER 85 61 34 84
PROAIR HFA 76 57 35 40
TRIAMTERENE-HCTZ 73 73 36 61
CLOPIDOGREL 72 65 37 43
TAMSULOSIN HCL 72 54 37 31
CRESTOR 70 41 39 26
LOSARTAN-HYDROCHLOROTHIAZIDE 70 62 39 38
FLUOXETINE HCL 64 56 41 52
AZITHROMYCIN 62 56 42 34
LIPITOR 62 53 42 119
PREDNISONE 60 58 44 35
SERTRALINE HCL 60 54 44 22
PROMETHAZINE HCL 55 21 R 46 81
AMITRIPTYLINE HCL 55 33 R 46 58
DILTIAZEM ER 53 53 48 174
DIOVAN 52 49 49 42
PLAVIX 52 49 49 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.